세계의 대동맥류 시장 : 산업 분석 : 규모, 점유율, 성장, 동향 및 예측(2024-2032년)

Persistence Market Research, a renowned market research firm, has conducted an in-depth analysis of the global Aortic Aneurysm Market. This comprehensive report provides valuable insights into key market dynamics, growth drivers, challenges, and emerging trends. It offers a detailed overview of the aortic aneurysm industry, presenting exclusive data and statistics projecting the market's growth trajectory from 2024 to 2032.

Key Insights:

• Aortic Aneurysm Market Size (2024): US$ 4.1 Billion
• Projected Market Value (2032): US$ 9.9 Billion
• Global Market Growth Rate (CAGR 2024 to 2032): 11.8%

Aortic Aneurysm Market - Report Scope:

The Aortic Aneurysm Market is witnessing significant growth, driven by increasing prevalence of aortic aneurysm conditions, advancements in diagnostic imaging techniques, and innovations in treatment modalities. This market serves patients, healthcare providers, and medical device manufacturers, offering a wide range of diagnostic tools, therapeutic interventions, and surgical procedures for aortic aneurysm management. Aortic aneurysms pose serious health risks, including rupture, dissection, and organ damage, necessitating timely diagnosis, monitoring, and treatment to prevent complications and improve patient outcomes. Market growth is fueled by aging population, lifestyle-related risk factors, and growing awareness about aortic aneurysm screening and management.

Market Growth Drivers:

The global Aortic Aneurysm Market benefits from several key growth drivers. Aging population and increasing prevalence of cardiovascular risk factors such as hypertension, smoking, and atherosclerosis drive market expansion. Aortic aneurysms are commonly associated with these risk factors, leading to rising incidence rates and demand for screening, diagnosis, and treatment services. Moreover, advancements in medical imaging technologies, including computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound, enable accurate detection and monitoring of aortic aneurysms, facilitating early intervention and risk stratification. The market is also influenced by innovations in minimally invasive procedures, endovascular techniques, and bioresorbable implants, offering safer and more effective treatment options for patients.

Market Restraints:

Despite its promising growth prospects, the Aortic Aneurysm Market faces challenges related to access to healthcare, reimbursement policies, and procedural risks. Limited access to specialized cardiovascular care and imaging facilities in rural and underserved areas may hinder timely diagnosis and treatment of aortic aneurysms, particularly in elderly and high-risk populations. Additionally, reimbursement limitations for screening and surveillance procedures may impact patient compliance and healthcare provider adoption of preventive measures. Furthermore, procedural risks associated with aortic aneurysm repair, including vascular complications, endoleak, and device migration, pose challenges for treatment outcomes and patient safety. Addressing these barriers requires collaboration between healthcare stakeholders, policymakers, and industry partners to improve access, affordability, and quality of care for aortic aneurysm patients.

Market Opportunities:

The Aortic Aneurysm Market presents significant growth opportunities driven by technological innovations, clinical research, and healthcare delivery reforms. The development of novel diagnostic biomarkers, risk prediction models, and imaging algorithms enables personalized risk assessment and patient stratification for targeted screening and surveillance programs. Moreover, advancements in endovascular devices, stent grafts, and tissue engineering techniques offer innovative solutions for aortic aneurysm repair, including fenestrated and branched endovascular repair, bioresorbable scaffolds, and regenerative therapies. Furthermore, integration of telemedicine, remote monitoring, and artificial intelligence (AI) technologies enhances patient engagement, care coordination, and outcomes optimization in the management of aortic aneurysm patients.

Competitive Intelligence and Business Strategy:

Leading players in the global Aortic Aneurysm Market, including [Insert Key Companies], focus on innovation, product differentiation, and market expansion to gain a competitive edge. These companies invest in research and development to develop next-generation diagnostic tools, therapeutic interventions, and surgical techniques for aortic aneurysm management. Moreover, strategic partnerships with healthcare providers, academic institutions, and research organizations enable companies to gain insights into market needs, clinical trends, and patient preferences. Furthermore, emphasis on patient education, awareness campaigns, and advocacy initiatives enhances brand visibility and trust in the competitive landscape of cardiovascular healthcare.

Key Companies Profiled:

• Medtronic
• Endologix LLC
• Gore Medical
• MicroPort Scientific Corporation
• Cook
• JOTEC
• Cardinal Health
• Terumo Corporation
• Lombard Medical
• AbbVie Inc

Aortic Aneurysm Market Research Segmentation:

Aortic Aneurysm by Type

• Aortic Aneurysm by Thoracic Aortic Aneurysm (TAA)
• Aortic Aneurysm by Abdominal Aortic Aneurysm (AAA)

Aortic Aneurysm Treatment

• Aortic Aneurysm by Open Surgical Repair (OSR)
• Aortic Aneurysm by Endovascular Aneurysm Repair (EVAR)

Aortic Aneurysm Product

• Aortic Aneurysm by Stent Grafts
• Aortic Aneurysm by Catheters

Aortic Aneurysm End User

• Aortic Aneurysm by Hospitals
• Aortic Aneurysm by Ambulatory Surgery Centers
• Aortic Aneurysm by Clinics

Aortic Aneurysm Region

• North America Aortic Aneurysm Market
• Latin America Aortic Aneurysm Market
• Europe Aortic Aneurysm Market
• Asia Pacific Aortic Aneurysm Market
• Middle East & Africa Aortic Aneurysm Market

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand-side Trends
• 1.3. Supply-side Trends
• 1.4. Technology Roadmap Analysis
• 1.5. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Market Background

• 3.1. Market Dynamics
  • 3.1.1. Drivers
  • 3.1.2. Restraints
  • 3.1.3. Opportunity
  • 3.1.4. Trends
• 3.2. Scenario Forecast
  • 3.2.1. Demand in Optimistic Scenario
  • 3.2.2. Demand in Likely Scenario
  • 3.2.3. Demand in Conservative Scenario
• 3.3. Opportunity Map Analysis
• 3.4. Investment Feasibility Matrix
• 3.5. PESTLE and Porter's Analysis
• 3.6. Regulatory Landscape
  • 3.6.1. By Key Regions
  • 3.6.2. By Key Countries
• 3.7. Regional Parent Market Outlook

4. Global Aortic Aneurysm Market Analysis 2019-2023 and Forecast, 2024-2032

• 4.1. Historical Market Size Value (US$ Bn) Analysis, 2019-2023
• 4.2. Current and Future Market Size Value (US$ Bn) Projections, 2024-2032
  • 4.2.1. Y-o-Y Growth Trend Analysis
  • 4.2.2. Absolute $ Opportunity Analysis

5. Global Aortic Aneurysm Market Analysis 2019-2023 and Forecast 2024-2032, By Type

• 5.1. Introduction / Key Findings
• 5.2. Historical Market Size Value (US$ Bn) Analysis By Type, 2019-2023
• 5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Type, 2024-2032
  • 5.3.1. Thoracic Aortic Aneurysm - TAA
  • 5.3.2. Abdominal Aortic Aneurysm - AAA
• 5.4. Y-o-Y Growth Trend Analysis By Type, 2019-2023
• 5.5. Absolute $ Opportunity Analysis By Type, 2024-2032

6. Global Aortic Aneurysm Market Analysis 2019-2023 and Forecast 2024-2032, By Treatment

• 6.1. Introduction / Key Findings
• 6.2. Historical Market Size Value (US$ Bn) Analysis By Treatment, 2019-2023
• 6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Treatment, 2024-2032
  • 6.3.1. Open Surgical Repair - OSR
  • 6.3.2. Endovascular Aneurysm Repair - EVAR
• 6.4. Y-o-Y Growth Trend Analysis By Treatment, 2019-2023
• 6.5. Absolute $ Opportunity Analysis By Treatment, 2024-2032

7. Global Aortic Aneurysm Market Analysis 2019-2023 and Forecast 2024-2032, By Product

• 7.1. Introduction / Key Findings
• 7.2. Historical Market Size Value (US$ Bn) Analysis By Product , 2019-2023
• 7.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Product , 2024-2032
  • 7.3.1. Stent Grafts
  • 7.3.2. Catheters
• 7.4. Y-o-Y Growth Trend Analysis By Product , 2019-2023
• 7.5. Absolute $ Opportunity Analysis By Product , 2024-2032

8. Global Aortic Aneurysm Market Analysis 2019-2023 and Forecast 2024-2032, By End-use

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size Value (US$ Bn) Analysis By End-use, 2019-2023
• 8.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By End-use, 2024-2032
  • 8.3.1. Hospitals
  • 8.3.2. Ambulatory Surgery Centers
  • 8.3.3. Clinics
• 8.4. Y-o-Y Growth Trend Analysis By End-use, 2019-2023
• 8.5. Absolute $ Opportunity Analysis By End-use, 2024-2032

9. Global Aortic Aneurysm Market Analysis 2019-2023 and Forecast 2024-2032, By Region

• 9.1. Introduction
• 9.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2019-2023
• 9.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2024-2032
  • 9.3.1. North America
  • 9.3.2. Latin America
  • 9.3.3. Europe
  • 9.3.4. Asia Pacific
  • 9.3.5. MEA
• 9.4. Market Attractiveness Analysis By Region

10. North America Aortic Aneurysm Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2032
  • 10.2.1. By Country
    • 10.2.1.1. U.S.
    • 10.2.1.2. Canada
  • 10.2.2. By Type
  • 10.2.3. By Treatment
  • 10.2.4. By Product
  • 10.2.5. By End-use
• 10.3. Market Attractiveness Analysis
  • 10.3.1. By Country
  • 10.3.2. By Type
  • 10.3.3. By Treatment
  • 10.3.4. By Product
  • 10.3.5. By End-use
• 10.4. Key Takeaways

11. Latin America Aortic Aneurysm Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2032
  • 11.2.1. By Country
    • 11.2.1.1. Brazil
    • 11.2.1.2. Mexico
    • 11.2.1.3. Rest of Latin America
  • 11.2.2. By Type
  • 11.2.3. By Treatment
  • 11.2.4. By Product
  • 11.2.5. By End-use
• 11.3. Market Attractiveness Analysis
  • 11.3.1. By Country
  • 11.3.2. By Type
  • 11.3.3. By Treatment
  • 11.3.4. By Product
  • 11.3.5. By End-use
• 11.4. Key Takeaways

12. Europe Aortic Aneurysm Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 12.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 12.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2032
  • 12.2.1. By Country
    • 12.2.1.1. Germany
    • 12.2.1.2. U.K.
    • 12.2.1.3. France
    • 12.2.1.4. Spain
    • 12.2.1.5. Italy
    • 12.2.1.6. Rest of Europe
  • 12.2.2. By Type
  • 12.2.3. By Treatment
  • 12.2.4. By Product
  • 12.2.5. By End-use
• 12.3. Market Attractiveness Analysis
  • 12.3.1. By Country
  • 12.3.2. By Type
  • 12.3.3. By Treatment
  • 12.3.4. By Product
  • 12.3.5. By End-use
• 12.4. Key Takeaways

13. Asia Pacific Aortic Aneurysm Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 13.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 13.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2032
  • 13.2.1. By Country
    • 13.2.1.1. China
    • 13.2.1.2. Japan
    • 13.2.1.3. South Korea
    • 13.2.1.4. Singapore
    • 13.2.1.5. Thailand
    • 13.2.1.6. Indonesia
    • 13.2.1.7. Australia
    • 13.2.1.8. New Zealand
    • 13.2.1.9. Rest of Asia Pacific
  • 13.2.2. By Type
  • 13.2.3. By Treatment
  • 13.2.4. By Product
  • 13.2.5. By End-use
• 13.3. Market Attractiveness Analysis
  • 13.3.1. By Country
  • 13.3.2. By Type
  • 13.3.3. By Treatment
  • 13.3.4. By Product
  • 13.3.5. By End-use
• 13.4. Key Takeaways

14. MEA Aortic Aneurysm Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 14.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 14.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2032
  • 14.2.1. By Country
    • 14.2.1.1. GCC Countries
    • 14.2.1.2. South Africa
    • 14.2.1.3. Israel
    • 14.2.1.4. Rest of MEA
  • 14.2.2. By Type
  • 14.2.3. By Treatment
  • 14.2.4. By Product
  • 14.2.5. By End-use
• 14.3. Market Attractiveness Analysis
  • 14.3.1. By Country
  • 14.3.2. By Type
  • 14.3.3. By Treatment
  • 14.3.4. By Product
  • 14.3.5. By End-use
• 14.4. Key Takeaways

15. Key Countries Aortic Aneurysm Market Analysis

• 15.1. U.S.
  • 15.1.1. Pricing Analysis
  • 15.1.2. Market Share Analysis, 2023
    • 15.1.2.1. By Type
    • 15.1.2.2. By Treatment
    • 15.1.2.3. By Product
    • 15.1.2.4. By End-use
• 15.2. Canada
  • 15.2.1. Pricing Analysis
  • 15.2.2. Market Share Analysis, 2023
    • 15.2.2.1. By Type
    • 15.2.2.2. By Treatment
    • 15.2.2.3. By Product
    • 15.2.2.4. By End-use
• 15.3. Brazil
  • 15.3.1. Pricing Analysis
  • 15.3.2. Market Share Analysis, 2023
    • 15.3.2.1. By Type
    • 15.3.2.2. By Treatment
    • 15.3.2.3. By Product
    • 15.3.2.4. By End-use
• 15.4. Mexico
  • 15.4.1. Pricing Analysis
  • 15.4.2. Market Share Analysis, 2023
    • 15.4.2.1. By Type
    • 15.4.2.2. By Treatment
    • 15.4.2.3. By Product
    • 15.4.2.4. By End-use
• 15.5. Germany
  • 15.5.1. Pricing Analysis
  • 15.5.2. Market Share Analysis, 2023
    • 15.5.2.1. By Type
    • 15.5.2.2. By Treatment
    • 15.5.2.3. By Product
    • 15.5.2.4. By End-use
• 15.6. U.K.
  • 15.6.1. Pricing Analysis
  • 15.6.2. Market Share Analysis, 2023
    • 15.6.2.1. By Type
    • 15.6.2.2. By Treatment
    • 15.6.2.3. By Product
    • 15.6.2.4. By End-use
• 15.7. France
  • 15.7.1. Pricing Analysis
  • 15.7.2. Market Share Analysis, 2023
    • 15.7.2.1. By Type
    • 15.7.2.2. By Treatment
    • 15.7.2.3. By Product
    • 15.7.2.4. By End-use
• 15.8. Spain
  • 15.8.1. Pricing Analysis
  • 15.8.2. Market Share Analysis, 2023
    • 15.8.2.1. By Type
    • 15.8.2.2. By Treatment
    • 15.8.2.3. By Product
    • 15.8.2.4. By End-use
• 15.9. Italy
  • 15.9.1. Pricing Analysis
  • 15.9.2. Market Share Analysis, 2023
    • 15.9.2.1. By Type
    • 15.9.2.2. By Treatment
    • 15.9.2.3. By Product
    • 15.9.2.4. By End-use
• 15.10. China
  • 15.10.1. Pricing Analysis
  • 15.10.2. Market Share Analysis, 2023
    • 15.10.2.1. By Type
    • 15.10.2.2. By Treatment
    • 15.10.2.3. By Product
    • 15.10.2.4. By End-use
• 15.11. Japan
  • 15.11.1. Pricing Analysis
  • 15.11.2. Market Share Analysis, 2023
    • 15.11.2.1. By Type
    • 15.11.2.2. By Treatment
    • 15.11.2.3. By Product
    • 15.11.2.4. By End-use
• 15.12. South Korea
  • 15.12.1. Pricing Analysis
  • 15.12.2. Market Share Analysis, 2023
    • 15.12.2.1. By Type
    • 15.12.2.2. By Treatment
    • 15.12.2.3. By Product
    • 15.12.2.4. By End-use
• 15.13. Singapore
  • 15.13.1. Pricing Analysis
  • 15.13.2. Market Share Analysis, 2023
    • 15.13.2.1. By Type
    • 15.13.2.2. By Treatment
    • 15.13.2.3. By Product
    • 15.13.2.4. By End-use
• 15.14. Thailand
  • 15.14.1. Pricing Analysis
  • 15.14.2. Market Share Analysis, 2023
    • 15.14.2.1. By Type
    • 15.14.2.2. By Treatment
    • 15.14.2.3. By Product
    • 15.14.2.4. By End-use
• 15.15. Indonesia
  • 15.15.1. Pricing Analysis
  • 15.15.2. Market Share Analysis, 2023
    • 15.15.2.1. By Type
    • 15.15.2.2. By Treatment
    • 15.15.2.3. By Product
    • 15.15.2.4. By End-use
• 15.16. Australia
  • 15.16.1. Pricing Analysis
  • 15.16.2. Market Share Analysis, 2023
    • 15.16.2.1. By Type
    • 15.16.2.2. By Treatment
    • 15.16.2.3. By Product
    • 15.16.2.4. By End-use
• 15.17. New Zealand
  • 15.17.1. Pricing Analysis
  • 15.17.2. Market Share Analysis, 2023
    • 15.17.2.1. By Type
    • 15.17.2.2. By Treatment
    • 15.17.2.3. By Product
    • 15.17.2.4. By End-use
• 15.18. GCC Countries
  • 15.18.1. Pricing Analysis
  • 15.18.2. Market Share Analysis, 2023
    • 15.18.2.1. By Type
    • 15.18.2.2. By Treatment
    • 15.18.2.3. By Product
    • 15.18.2.4. By End-use
• 15.19. South Africa
  • 15.19.1. Pricing Analysis
  • 15.19.2. Market Share Analysis, 2023
    • 15.19.2.1. By Type
    • 15.19.2.2. By Treatment
    • 15.19.2.3. By Product
    • 15.19.2.4. By End-use
• 15.20. Israel
  • 15.20.1. Pricing Analysis
  • 15.20.2. Market Share Analysis, 2023
    • 15.20.2.1. By Type
    • 15.20.2.2. By Treatment
    • 15.20.2.3. By Product
    • 15.20.2.4. By End-use

16. Market Structure Analysis

• 16.1. Competition Dashboard
• 16.2. Competition Benchmarking
• 16.3. Market Share Analysis of Top Players
  • 16.3.1. By Regional
  • 16.3.2. By Type
  • 16.3.3. By Treatment
  • 16.3.4. By Product
  • 16.3.5. By End-use

17. Competition Analysis

• 17.1. Competition Deep Dive
  • 17.1.1. Medtronic
    • 17.1.1.1. Overview
    • 17.1.1.2. Product Portfolio
    • 17.1.1.3. Profitability by Market Segments
    • 17.1.1.4. Sales Footprint
    • 17.1.1.5. Strategy Overview
      • 17.1.1.5.1. Marketing Strategy
  • 17.1.2. Endologix LLC
    • 17.1.2.1. Overview
    • 17.1.2.2. Product Portfolio
    • 17.1.2.3. Profitability by Market Segments
    • 17.1.2.4. Sales Footprint
    • 17.1.2.5. Strategy Overview
      • 17.1.2.5.1. Marketing Strategy
  • 17.1.3. Gore Medical
    • 17.1.3.1. Overview
    • 17.1.3.2. Product Portfolio
    • 17.1.3.3. Profitability by Market Segments
    • 17.1.3.4. Sales Footprint
    • 17.1.3.5. Strategy Overview
      • 17.1.3.5.1. Marketing Strategy
  • 17.1.4. MicroPort Scientific Corporation
    • 17.1.4.1. Overview
    • 17.1.4.2. Product Portfolio
    • 17.1.4.3. Profitability by Market Segments
    • 17.1.4.4. Sales Footprint
    • 17.1.4.5. Strategy Overview
      • 17.1.4.5.1. Marketing Strategy
  • 17.1.5. Cook
    • 17.1.5.1. Overview
    • 17.1.5.2. Product Portfolio
    • 17.1.5.3. Profitability by Market Segments
    • 17.1.5.4. Sales Footprint
    • 17.1.5.5. Strategy Overview
      • 17.1.5.5.1. Marketing Strategy
  • 17.1.6. JOTEC
    • 17.1.6.1. Overview
    • 17.1.6.2. Product Portfolio
    • 17.1.6.3. Profitability by Market Segments
    • 17.1.6.4. Sales Footprint
    • 17.1.6.5. Strategy Overview
      • 17.1.6.5.1. Marketing Strategy
  • 17.1.7. Cardinal Health
    • 17.1.7.1. Overview
    • 17.1.7.2. Product Portfolio
    • 17.1.7.3. Profitability by Market Segments
    • 17.1.7.4. Sales Footprint
    • 17.1.7.5. Strategy Overview
      • 17.1.7.5.1. Marketing Strategy
  • 17.1.8. Terumo Corporation
    • 17.1.8.1. Overview
    • 17.1.8.2. Product Portfolio
    • 17.1.8.3. Profitability by Market Segments
    • 17.1.8.4. Sales Footprint
    • 17.1.8.5. Strategy Overview
      • 17.1.8.5.1. Marketing Strategy
  • 17.1.9. Lombard Medical
    • 17.1.9.1. Overview
    • 17.1.9.2. Product Portfolio
    • 17.1.9.3. Profitability by Market Segments
    • 17.1.9.4. Sales Footprint
    • 17.1.9.5. Strategy Overview
      • 17.1.9.5.1. Marketing Strategy
  • 17.1.10. AbbVie Inc
    • 17.1.10.1. Overview
    • 17.1.10.2. Product Portfolio
    • 17.1.10.3. Profitability by Market Segments
    • 17.1.10.4. Sales Footprint
    • 17.1.10.5. Strategy Overview
      • 17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology